Nerve cells grown from stem cells give new insight into Parkinson's

June 20, 2011
Nerve cells grown from stem cells give new insight into Parkinson's
Dopamine neurons (in green) grown using stem cell technology.

Oxford University researchers have succeeded in using stem cell technology to grow nerve cells in the laboratory from initial skin samples taken from Parkinson’s patients. It’s the first large-scale effort of its kind in the UK.

The advance will allow that are just like those of the people with Parkinson’s to be studied intensively in the laboratory in ways that weren’t possible before.

The study aims to investigate what processes are making specific nerve cells, called dopamine neurons, die off as the disease progresses.

"We can’t take bits of people’s brains when they are alive, of course," says Dr. Richard Wade-Martins of the Oxford Parkinson’s Disease Centre, who led the work. "So we never have been able to study dopamine neurons from a patient."

"We now have a platform to understand what happens in the cells in disease and identify new pathways that could lead to potential targets for new therapies."

BBC News followed the steps in the process with one patient from Oxfordshire. A skin biopsy was provided by Mr Derek Underwood, who used to work for a manufacturer of MRI scanners before his early retirement through Parkinson’s.

Skin cells from Mr. Underwood’s biopsy were then grown up in the lab. At the appropriate point, using an approach recently developed by Japanese scientists, the skin cells were ‘reprogrammed’ to revert back to a stem-cell-like state.

The great power of these induced pluripotent , or iPS cells, is that they are able to form just about any of the specialised types of cell present in the body. That allowed the Oxford team to guide the iPS cells to develop, or ‘differentiate’, into nerve cells that are essentially identical to the Mr. Underwood’s own nerve cells in his brain.

Some of the nerve cells generated are dopamine neurons, the ones involved in Parkinson’s disease.

Each of the stages in the process – skin cells to iPS cells to nerve cells – are visible under the microscope as they all look very different. The clearly defined circular colony of stem cells gradually breaks up as nerve cells with their long thread-like projections appear, down which electrical signals can be transmitted.

Being able to access large numbers of the in the lab should allow the study of all the biological processes that go wrong in Parkinson’s, giving greater insight into the causes of the disease.

"The brain is an inaccessible organ and you can't get bits of people's brain to study very easily," Dr. Richard Wade-Martins told BBC News. "But what we have here is a disease in a dish [where the cells] are just like Derek's brain cells but are accessible and can be produced in unlimited quantities."

Dr. Wade-Martins and colleagues now have samples from 20 different patients with Parkinson’s disease, all at different stages in the stem cell process. This gives a bank of samples for study.

The stem cell work is part of a bigger clinical study funded by Parkinson’s UK involving around 2000 people with Parkinson’s disease in the Thames Valley region.

The study is using a series of approaches – blood screens, gene sequencing, cell cultures, and MRI scans – to get a lot of clinical data about this set of patients to really probe the origins and causes of the condition.

"We’re interested in biomarkers that can be predictors of disease, whether that’s aberrant proteins in the blood or MRI imaging signatures," explains Dr. Wade-Martins.

"It’s not a clinical trial of a drug, nor are we using stem cells as a therapy. What we will get is a fantastically well-characterised cohort of people that should help us pinpoint disease mechanisms."

Explore further: Identification of dopamine 'mother cells' could lead to future Parkinson's treatments

Related Stories

Skin cells could help discover cause of Parkinson's disease

July 14, 2010

Researchers are applying new stem cell technology to use skin samples to grow the brain cells thought to be responsible for the onset of Parkinson's disease, the UK National Stem Cell Network (UKNSCN) annual science meeting ...

Stem cells reverse disease in a model of Parkinson's disease

May 16, 2011

In a new study to be published in the Journal of Clinical Investigation, researchers compared the ability of cells derived from different types of human stem cell to reverse disease in a rat model of Parkinson disease and ...

Recommended for you

New method creates endless supply of kidney precursor cells

August 25, 2016

Salk Institute scientists have discovered the holy grail of endless youthfulness—at least when it comes to one type of human kidney precursor cell. Previous attempts to maintain cultures of the so-called nephron progenitor ...

Strict diet combats rare progeria aging disorders

August 25, 2016

Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want. These are findings of a joint study being published today ...

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.